Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Cyanotech Corporation (NasdaqNM:CYAN)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials
Recent Events
July 26Conference call: Cyanotech Quarterly
Location
73-4460 Queen Kaahumanu Hwy., Suite 102
Kailua-Kona, HI 96740
Phone: (808) 326-1353
Fax: (808) 329-3597
Email: brucerussell@mediaone.net
Employees (last reported count): 53
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 16%
·Over the last 6 months:
 · 6 insider buys; 55.0K shares (2.1% of insider shares)
·Institutional: 1% (1% of float)
(7 institutions)
·Net Inst. Selling: 250.0K shares
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Cyanotech Corporation is engaged in the development and commercialization of natural products derived from microalgae. The Company produces natural products from microalgae for the nutritional supplement, aquaculture feed, animal nutrition and immunological diagnostics markets. Cyanotech has been producing microalgae-based "Spirulina" products for the vitamin and supplement market. Spirulina Pacifica is a strain of Spirulina that provides a vegetable-based, highly absorbable source of natural beta-carotene, mixed carotenoids, B vitamins, gamma linolenic acid, protein, essential amino acids and other phytonutrients. NatuRose is the brand name of its natural astaxanthin product for the animal nutrition market, which the Company produces from the microalgae, Haematococcus. In March 1999, the Company announced the development of BioAstin, its natural astaxanthin product for the human nutrition market.
More from Market Guide: Expanded Business Description

Financial Summary
CYAN develops and commercializes products from microalgae for nutritional supplement and immunological diagnostics markets. For the three months ended 6/30/01, revenues increased 7% to $2.3 million. Net loss applicable to Common totaled $413 thousand, up from $61 thousand. Revenues reflect increased sales of packaged consumer products, packaged private label products and bulk spirulina products. Higher loss reflects increased advertising and promotion expenses.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Gerald Cysewski, Ph.D., 51
Chairman, Pres and CEO
$103K
Ronald Scott, 45
Exec. VP of Fin. and Admin., Sec., Treasurer
--  
Glenn Jensen, 41
VP of Operations
--  
Kelly Moorhead, 44
VP of Sales and Marketing
--  
Dollar amounts are as of 31-Mar-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:CYANAs of 31-Aug-2001
Price and Volume
52-Week Low
on 29-Dec-2000
$0.625
Recent Price$1.00 
52-Week High
on 11-Sep-2000
$2.00 
Beta0.93 
Daily Volume (3-month avg)29.1K
Daily Volume (10-day avg)25.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-45.8%
52-Week Change
relative to S&P500
-27.2%
Share-Related Items
Market Capitalization$17.0M
Shares Outstanding17.0M
Float14.3M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.90 
Earnings (ttm)-$0.09 
Earnings (mrq)-$0.02 
Sales (ttm)$0.50 
Cash (mrq)$0.08 
Valuation Ratios
Price/Book (mrq)1.11 
Price/EarningsN/A 
Price/Sales (ttm)2.02 
Income Statements
Sales (ttm)$8.19M
EBITDA (ttm)$431.0K
Income available to common (ttm)-$1.46M
Profitability
Profit Margin (ttm)-17.8%
Operating Margin (ttm)-12.8%
Fiscal Year
Fiscal Year EndsMar 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-6.71%
Return on Equity (ttm)-9.01%
Financial Strength
Current Ratio (mrq)2.19 
Debt/Equity (mrq)0.29 
Total Cash (mrq)$1.43M
Short Interest
As of 8-Aug-2001
Shares Short9,000 
Percent of Float0.1%
Shares Short
(Prior Month)
4,000 
Short Ratio0.43 
Daily Volume21.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.